SABRTOOTH: A randomised controlled feasibility study of Stereotactic Ablative Radiotherapy (SABR) with surgery in paTients with peripheral stage I nOn-small cell lung cancer (NSCLC) cOnsidered To be at Higher risk of complications from surgical resection

Kevin N Franks, Lucy McParland, Joanne Webster, David R Baldwin, David Sebag-Montefiore, Matthew Evison, Richard Booton, Corinne Faivre-Finn, Babu Naidu, Jonathan Ferguson, Clive Peedell, Matthew EJ Callister, Martyn Kennedy, Jenny Hewison, Janine Bestall, Walter M Gregory, Peter Hall, Fiona Collinson, Catherine Olivier, Rachel NaylorSue Bell, Peter Allen, Andrew Sloss, Michael Snee

Deanery of Molecular, Genetic and Population Health Sciences
Edinburgh Cancer Research Centre
Edinburgh Clinical Trials Unit

Research output: Contribution to journal › Article › peer-review

1 results
- Last Name(descending)

Peter Hall
- Edinburgh Cancer Research Centre
- Edinburgh Clinical Trials Unit
- School of Genetics and Cancer - Personal Chair of Medical Oncology (Cancer Informatics)
Person: Academic: Research Active (Teaching)

SABRTOOTH: A randomised controlled feasibility study of Stereotactic Ablative Radiotherapy (SABR) with surgery in paTients with peripheral stage I nOn-small cell lung cancer (NSCLC) cOnsidered To be at Higher risk of complications from surgical resection

Profiles

Search results

Peter Hall